MedPath
NMPA Approval

Dextromethorphan Hydrobromide, Guaifenesin and Pseudoephedrine Hydrochloride Tablets

国药准字H20217013

January 20, 2021

国药准字H10950232

Drug Information

美酚伪麻片

片剂

复方

化学药品

January 20, 2021

Company Information

Applicant Company

眉山经济开发区新区香樟路5号

Manufacturing Company

四川省眉山经济开发区新区香樟路5号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

美酚伪麻片 - NMPA 批准文号 | MedPath